— Know what they know.
Not Investment Advice
Also trades as: CVSG.L (LSE) · $vol 4M

CVSGF OTC

CVS Group plc
1W: +0.0% 1M: +0.0% 3M: +0.3% YTD: +2.3% 1Y: +1.8% 3Y: -29.6% 5Y: -50.9%
$16.60
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Care Facilities · Tech Score Sell · Power 51 · $1.1B mcap · 68M float · 0.0005% daily turnover · Short 100% of daily vol

Cash Flow Trends

Operating Cash Flow
$70M -37.8% ▼
5Y CAGR: +3.1%
Capital Expenditures
$28M +22.6% ▲
5Y CAGR: +11.1%
Free Cash Flow
$42M -44.9% ▼
5Y CAGR: -0.7%
Dividends Paid
$6M +23.3% ▲
Buybacks
$31M +0.0% ▲
Net Change in Cash
$2M +37.0% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
— Operating Activities —
Net Income$26M$42M$6M$53M$17M
Depreciation & Amort.$48M$50M$58M$64M$64M
Stock-Based Comp.$2M$2M$2M$0$0
Change in Working Capital-$12M-$9M-$10M-$4M-$16M
Other Non-Cash Items$7M$11M$11M-$887K$5M
Operating Cash Flow$76M$84M$68M$113M$70M
— Investing Activities —
Capital Expenditures-$24M-$46M-$40M-$26M-$36M
Acquisitions (Net)-$8M-$55M-$97M-$31M-$45M
Investment Purchases-$21M$3M-$600K$0$0
Investment Sales$9M$100K$0$0$0
Other Investing$200K-$3M-$3M$26M$394K
Investing Cash Flow-$45M-$100M-$140M-$31M-$80M
— Financing Activities —
Net Debt Issuance-$100K$10M$89M-$51M$67M
Stock Repurchased$0-$1M-$900K$0-$31M
Dividends Paid-$5M-$5M-$5M-$8M-$6M
Other Financing-$13M-$18M-$16M-$23M-$17M
Financing Cash Flow-$15M-$12M$68M-$81M$12M
Net Change in Cash$15M-$28M-$5M$1M$2M
Cash End of Period$49M$22M$16M$22M$18M
Free Cash Flow$51M$39M$25M$76M$42M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms